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Ayub et al., page 176
It has been over 50 years since Jim Neel asked, ‘‘If the
considerable frequency of the disease is of relatively long
duration in the history of our species, how can this be
accounted for in the face of the obvious and strong genetic
selection against the condition? If, on the other hand,
this frequency is a relatively recent phenomenon, what
changes in the environment are responsible for the
increase’’? In considering this conundrum, he developed
the idea of ‘‘thrifty genes’’: a ‘‘thrifty’’ genotype would
have been advantageous at some time in human history
(say, during times of food scarcity), but in modern times,
when ‘‘feast’’ is more the rule than the exception, this
genotype would no longer be beneficial and would instead
render individuals susceptible to modern diseases such as
diabetes. This idea has gained many supporters, but
‘‘proof’’ has been lacking. In this issue, Ayub et al.
harnessed the vast amount of data available from recent
genome-wide association studies (GWASs) in conjunction
with information about haplotype structure and popula-
tion genetics. Although they found evidence for some
amount of positive selection at a few GWAS loci, their
overall analysis suggests that today’s high prevalence of
type 2 diabetes cannot be explained by the thrifty-gene
hypothesis.Mendelian Randomization Probes the
Relationship between BMI and Coronary Heart
Disease
Holmes et al., page 198
Although it is clear that BMI has a relationship with heart
disease, stroke, and risk of type 2 diabetes, determining
the nature of the relationship between BMI and these
health conditions can be confounded because of many
environmental and lifestyle factors. One approach to
circumvent the obstacles in observational studies is the
use of Mendelian randomization. This approach interro-
gates the relationship between the health outcome and
the genotypes associated with a trait that might predis-
pose an individual to such an outcome because these
genotypes should randomly assort in a large population.
For example, in this study, Holmes et al. used a Mende-1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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ship between cardiometabolic traits at SNPs previously
identified to be associated with BMI in approximately
35,000 people to determine whether BMI has a causal
relationship with these cardiometabolic traits. They
found that BMI does appear to have a causal relationship
with risk factors for coronary heart disease, such as
fasting glucose and insulin levels, interleukin 6 levels,
blood pressure, and type 2 diabetes. However, there did
not appear to be a causal relationship between BMI and
coronary heart disease itself or stroke. Because this
approach depends on previously identified SNPs associ-
ated with the trait of interest (BMI in this case), it will
be interesting to see how the use of Mendelian random-
ization might help examine or further refine the
genome-wide association data amassed in larger and
larger studies to unravel complicated relationships for
other disease outcomes.Uncovering Rare Variants
Lange et al., page 233; Peloso et al., page 223
An experimental framework of large-scale exome
sequencing followed by focused genotyping has been pro-
posed for testing for associations between rare variants
and common diseases. Indeed, it was on this principle
that the Exome Chip was designed. In this issue, two
groups utilized variations of this strategy to search for
rare variants associated with cholesterol and triglyceride
levels. Focusing attention on those whose low-density
lipoprotein cholesterol (LDL-C) levels lie at the extremes
of the spectrum, Lange et al. sequenced a cohort of
~2,000 individuals. Through their analysis and follow-
up genotyping, they identified a burden of low-frequency
and rare alleles in four genes, including PNPLA5. Notably,
the authors suggest that the Exome Chip will have
limited utility for the study of rare variants. By contrast,
Peloso et al. used the Exome Chip to genotype over
50,000 individuals for whom LDL-C, high-density lipo-
protein cholesterol (HDL-C), and triglyceride levels had
been measured. They uncovered low-frequency and rare
variants associated with HDL-C and/or triglyceride levels,
but unlike Lange et al., they found no new associations
for LDL-C levels. Although the two groups set out to
investigate a similar question, the differing approachesy of Human Genetics. All rights reserved.
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and nonoverlapping results suggest that the rare-variant
space is indeed ripe for both methodological development
and discovery.Deciding Whom to Sequence
Cheung et al., page 257
Family-based studies form a cornerstone of human
genetics research, and as the search for rare disease-asso-
ciated variants ramps up, they can provide an attractive
alternative to large case-control studies. However, as we
are all aware, funding is not unlimited, and so decisions
need to be made regarding which family members should
be sequenced. Success at this stage ensures that down-
stream imputation will be informative, thus increasing
the chances of detecting causal variants. Until now, these
decisions have been made on a fairly ad hoc basis, i.e.,
investigators have drawn on their experience with similar
studies. In this issue, Cheung et al. introduce GIGI-PICK,
a method that automates this decision-making process
and promises to choose the most informative family
members for sequencing. Importantly, GIGI-PICK pro-
vides investigators with some amount of flexibility, for
instance, by factoring into account who in a given pedi-
gree has already been sequenced or leveraging available
phenotype information. This new method should have
immediate utility in several ongoing family-based
sequencing projects, potentially providing biological
insight into a variety of human diseases.158 The American Journal of Human Genetics 94, 157–158, FebruaryAlternative Transcription Start Site Might Explain
the Phenotypic Range of YAP1 Mutations
Williamson et al., page 295
YAP1 is an important component in the HIPPO signaling
pathway, which acts to control cell size and proliferation.
Much of the attention directed at YAP1 stems from the
growing appreciation of its role in cancer. However, in
this study, Williamson et al. used exome sequencing to
identify heterozygous nonsense mutations in YAP1 in
two families affected by autosomal-dominant coloboma.
Although both families shared the coloboma phenotype,
one family also presented with hearing loss, intellectual
disability, hematuria, and orofacial clefting. The isolated
coloboma phenotype corresponded to a mutation closer
to the 50 end of YAP1 than to the mutation causing a range
of phenotypes. To determine why nonsense mutations in
the same gene might cause more severe phenotypes in
one family, the authors searched for alternative transcrip-
tion start sites (TSSs). Upon examination, a second TSS
that initiates between the two mutations was identified.
Transcripts from this alternative TSS would be unaltered
by the mutation identified in the less severely affected
family but would be altered by the mutation identified in
the more severely affected family. The smaller transcript
does not encode one of the two WW domains that have
been previously shown to be important for YAP1 function.
Further studies will help to clarify to what extent each
isoform can affect HIPPO signaling and influence develop-
mental pathways.6, 2014
